Vanguard Global Advisers’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Sell
73,896
-98
-0.1% -$1.88K ﹤0.01% 1355
2026
Q1
$1.3M Buy
+73,994
New +$1.49M ﹤0.01% 1474

Other funds holding ALHC

Vanguard Global Advisers's ALHC Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Alignment Healthcare (ALHC) stake by 0.13% in Q2 2026, selling an estimated $1.88K and leaving 73,896 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1355.

Vanguard Global Advisers first reported a position in ALHC in Q1 2026 and has held it in 2 quarters since. 320 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Vanguard Global Advisers held 73,896 shares of Alignment Healthcare worth $1.76M as of Q2 2026.
  • Vanguard Global Advisers sold 98 Alignment Healthcare shares in Q2 2026, an estimated $1.88K.
  • Alignment Healthcare made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1355 holding.
  • Vanguard Global Advisers first reported a position in Alignment Healthcare in Q1 2026 and has held it in 2 quarters since.
  • 320 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.